Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurochem
2010 Aug 01;1144:994-1006. doi: 10.1111/j.1471-4159.2010.06819.x.
Show Gene links
Show Anatomy links
Alexa Fluor 546-ArIB[V11L;V16A] is a potent ligand for selectively labeling alpha 7 nicotinic acetylcholine receptors.
Hone AJ
,
Whiteaker P
,
Mohn JL
,
Jacob MH
,
McIntosh JM
.
???displayArticle.abstract???
The alpha7* (*denotes the possible presence of additional subunits) nicotinic acetylcholine receptor (nAChR) subtype is widely expressed in the vertebrate nervous system and implicated in neuropsychiatric disorders that compromise thought and cognition. In this report, we demonstrate that the recently developed fluorescent ligand Cy3-ArIB[V11L;V16A] labels alpha7 nAChRs in cultured hippocampal neurons. However, photobleaching of this ligand during long image acquisition times prompted us to develop a new derivative. In photostability studies, this new ligand, Alexa Fluor 546-ArIB[V11L;V16A], was significantly more resistant to bleaching than the Cy3 derivative. The classic alpha7 ligand alpha-bungarotoxin binds to alpha1* and alpha9* nAChRs. In contrast, Alexa Fluor 546-ArIB[V11L;V16A] potently (IC(50) 1.8 nM) and selectively blocked alpha7 nAChRs but not alpha1* or alpha9* nAChRs expressed in Xenopus oocytes. Selectivity was further confirmed by competition binding studies of native nAChRs in rat brain membranes. The fluorescence properties of Alexa Fluor 546-ArIB[V11L;V16A] were assessed using human embryonic kidney-293 cells stably transfected with nAChRs; labeling was observed on cells expressing alpha7 but not cells expressing alpha3beta2, alpha3beta4, or alpha4beta2 nAChRs. Further imaging studies demonstrate that Alexa Fluor 546-ArIB[V11L;V16A] labels hippocampal neurons from wild-type mice but not from nAChR alpha7 subunit-null mice. Thus, Alexa Fluor 546-ArIB[V11L;V16A] represents a potent and selective ligand for imaging alpha7 nAChRs.
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009, Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Albuquerque,
Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine.
1998,
Pubmed
Alkondon,
A non-alpha7 nicotinic acetylcholine receptor modulates excitatory input to hippocampal CA1 interneurons.
2002,
Pubmed
Alkondon,
Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.
1999,
Pubmed
Alkondon,
Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices.
1997,
Pubmed
Bencherif,
Alpha7 neuronal nicotinic receptors: the missing link to understanding Alzheimer's etiopathology?
2010,
Pubmed
Berlier,
Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates.
2003,
Pubmed
Biallas,
Immunohistochemical detection of nicotinic acetylcholine receptor subunits alpha9 and alpha10 in rat lung isografts and allografts.
2007,
Pubmed
Buccafusco,
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.
2009,
Pubmed
Buckley,
Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells.
1985,
Pubmed
,
Xenbase
Buhler,
alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons.
2002,
Pubmed
Cartier,
A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
1996,
Pubmed
,
Xenbase
Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed
Dávila-García,
[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors.
1997,
Pubmed
Dziewczapolski,
Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease.
2009,
Pubmed
Elgoyhen,
alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.
2001,
Pubmed
,
Xenbase
Elgoyhen,
Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells.
1994,
Pubmed
,
Xenbase
Fayuk,
Dendritic Ca2+ signalling due to activation of alpha 7-containing nicotinic acetylcholine receptors in rat hippocampal neurons.
2007,
Pubmed
Franceschini,
Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures.
2002,
Pubmed
Frazier,
Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells.
1998,
Pubmed
Frazier,
Nicotinic receptors on local circuit neurons in dentate gyrus: a potential role in regulation of granule cell excitability.
2003,
Pubmed
Fucile,
Fractional Ca(2+) current through human neuronal alpha7 nicotinic acetylcholine receptors.
2003,
Pubmed
Gahring,
Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus.
2004,
Pubmed
Grau,
Administration of keratinocyte growth factor (KGF) modulates the pulmonary expression of nicotinic acetylcholine receptor subunits alpha7, alpha9 and alpha10.
2007,
Pubmed
Haberberger,
Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat.
2004,
Pubmed
Hauser,
TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.
2009,
Pubmed
Herber,
Biochemical and histochemical evidence of nonspecific binding of alpha7nAChR antibodies to mouse brain tissue.
2004,
Pubmed
Hone,
A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors.
2009,
Pubmed
,
Xenbase
Kannenberg,
Clusters of GABAA receptors on cultured hippocampal cells correlate only partially with functional synapses.
1999,
Pubmed
Kawai,
Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins.
2002,
Pubmed
Khiroug,
Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons.
2003,
Pubmed
Mao,
The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo.
2008,
Pubmed
Marchionni,
In the developing rat hippocampus a tonic GABAA-mediated conductance selectively enhances the glutamatergic drive of principal cells.
2007,
Pubmed
Marks,
Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.
2009,
Pubmed
Massey,
BDNF up-regulates alpha7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons.
2006,
Pubmed
McCann,
The cholinergic antagonist alpha-bungarotoxin also binds and blocks a subset of GABA receptors.
2006,
Pubmed
,
Xenbase
McQuiston,
Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus.
1999,
Pubmed
Mexal,
Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.
2010,
Pubmed
Moser,
Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures.
2007,
Pubmed
Orr-Urtreger,
Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents.
1997,
Pubmed
Palma,
Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine.
1996,
Pubmed
,
Xenbase
Panchuk-Voloshina,
Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates.
1999,
Pubmed
Peng,
Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes.
2004,
Pubmed
Perry,
[3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.
1995,
Pubmed
Placzek,
Nicotinic mechanisms influencing synaptic plasticity in the hippocampus.
2009,
Pubmed
Rosenberg,
Adenomatous polyposis coli plays a key role, in vivo, in coordinating assembly of the neuronal nicotinic postsynaptic complex.
2008,
Pubmed
Salminen,
The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.
2005,
Pubmed
Sgard,
A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit.
2002,
Pubmed
,
Xenbase
Sharma,
Action potential-independent and nicotinic receptor-mediated concerted release of multiple quanta at hippocampal CA3-mossy fiber synapses.
2008,
Pubmed
Sinkus,
A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia.
2009,
Pubmed
Sudweeks,
Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons.
2000,
Pubmed
Szabo,
Intracellular Ca2+ dynamics of hippocampal interneurons following nicotinic acetylcholine receptor activation.
2008,
Pubmed
Tretter,
The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin.
2008,
Pubmed
Tsuneki,
Mouse muscle denervation increases expression of an alpha7 nicotinic receptor with unusual pharmacology.
2003,
Pubmed
Wang,
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.
2003,
Pubmed
Whiteaker,
Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
2000,
Pubmed
Whiteaker,
Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
2007,
Pubmed
,
Xenbase
Whiteaker,
Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist.
2008,
Pubmed
,
Xenbase
Whiteaker,
125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.
2000,
Pubmed
Xiao,
Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.
2009,
Pubmed
Xiao,
The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
2004,
Pubmed
Xiao,
Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
1998,
Pubmed
Zhao,
Nicotine-induced Ca2+-myristoyl switch of neuronal Ca2+ sensor VILIP-1 in hippocampal neurons: a possible crosstalk mechanism for nicotinic receptors.
2009,
Pubmed
Zhao,
Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.
2003,
Pubmed
Zhong,
Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors.
2008,
Pubmed
